Inflammaging and the Skin.

J Invest Dermatol

Centre for Dermatology Research, Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom; Lydia Becker Institute of Immunology and Inflammation, The University of Manchester, Manchester, United Kingdom; Manchester Institute for Collaborative Research on Aging, The University of Manchester, Manchester, United Kingdom; NIHR Manchester Biomedical Research Centre, The University of Manchester, Manchester, United Kingdom.

Published: April 2021

As global life expectancy continues to rise, we are challenged with maintaining health into old age. One strategy is to target the chronic low-level inflammation associated with aging, termed inflammaging. This is characterized by increased levels of circulating proinflammatory cytokines and a shift toward cellular senescence, changes that are believed to drive many age-associated conditions, including dementia, arthritis, and type 2 diabetes. As with other organs, the skin undergoes functional decline during aging, becoming more fragile and susceptible to infection; however, the contribution of inflammaging is not well-understood. This review article describes the evidence for inflammaging in the skin, its relationship with senescence, and how this relates to declining skin structure and function.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jid.2020.11.006DOI Listing

Publication Analysis

Top Keywords

inflammaging skin
8
inflammaging
4
skin global
4
global life
4
life expectancy
4
expectancy continues
4
continues rise
4
rise challenged
4
challenged maintaining
4
maintaining health
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!